GWSG
CORT icon

GPS Wealth Strategies Group’s Corcept Therapeutics CORT Stock Holding History

GPS Wealth Strategies Group’s Portfolio CORT Stock Details CORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-29
Closed -$2.41K – 753
2025
Q3 		$2.41K Buy
+29
New +$2.1K ﹤0.01% 1395
2023
Q2 		– Sell
-150
Closed -$3.25K – 1258
2023
Q1 		$3.25K Buy
+150
New +$3.29K ﹤0.01% 1051
2022
Q4 		– Sell
-150
Closed -$4K – 310
2022
Q3 		$4K Buy
+150
New +$4.01K ﹤0.01% 921

Other funds holding CORT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $2.83B AUM 21.61% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PA
Parallel Advisors San Francisco, California $5.56B AUM 17.89% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

GPS Wealth Strategies Group's CORT Position: Q4 2025 in Review

GPS Wealth Strategies Group sold out of Corcept Therapeutics (CORT) in Q4 2025, closing a stake of 29 shares — an estimated $2.41K sold.

GPS Wealth Strategies Group first reported a position in CORT in Q3 2022 and held it in 3 quarters. The position peaked at $4K in Q3 2022. 389 funds tracked by Wall St. Rank hold CORT as of Q4 2025.

  • GPS Wealth Strategies Group reported no remaining Corcept Therapeutics position as of Q4 2025 after selling out during the quarter.
  • GPS Wealth Strategies Group sold 29 Corcept Therapeutics shares in Q4 2025, an estimated $2.41K.
  • GPS Wealth Strategies Group first reported a position in Corcept Therapeutics in Q3 2022 and held it in 3 quarters.
  • GPS Wealth Strategies Group's Corcept Therapeutics position peaked at $4K in Q3 2022.
  • 389 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q4 2025.

Based on GPS Wealth Strategies Group's 13F filing for Q4 2025, filed 6 Feb 2026.